Comprehensive Medical Weight Loss
Get the latest developments in medical weight loss at Clinical Nutrition Center in Denver, Colorado, a doctor-supervised weight loss center. Ethan Lazarus, MD is a medical weight loss doctor helping patients achieve long-term weight control.
The New Year is here now, and I wanted to take a moment and share with you exciting updates for Denver residents regarding medical weight loss programs and medications for 2013. As we all know, 2012 was a very important year for medical weight loss centers around the country for several reasons including:
For many years, Dr. Lazarus and the staff at CNC have utilized low carbohydrate diets to achieve weight loss. This remains a common practice among medical weight loss doctors. But what about long-term maintenance of weight loss?
Dr. Ethan Lazarus is attending the Medical Weight Loss lecture series in Orlando, Florida this week. The ASBP meeting attracts about 500 doctors specializing in medical weight loss from across the country. Dr. Lazarus was a featured speaker at this year’s meeting, helping prepare weight loss doctors for the upcoming Obesity Medicine board examination next month.
Dr. Ethan Lazarus is heading to Orlando, Florida to present at the National American Society of Bariatric Physicians Obesity Medicine Board Review Course. He'll be covering 3 topics:
The Joslin Diabetes Center in Boston has proven that patients lost weight and kept it off through a short-term, intensive weight loss program. The study showed half of the patients maintained an average of 9.5% weight loss at four years…
Earlier this month, both the U.S. Preventive Services Task Force (USPSTF) and the American Academy of Family Physicians (AAFP) updated their recommendations regarding Obesity. For the first time, both now recommend that all adults be screened for obesity. Individuals with…
After more than a decade with no new medications to treat obesity, today the FDA approved the obesity drug Lorcaserin, to be marketed later this year as Belviq. In clinical trials, the drug helped individuals lose an average of 5.7%…
Shortly after recommending approval of Qnexa (Phentermine / Topiramate), the FDA advisory panel this week also voted to approve Arena Pharmaceuticals weight loss drug, Lorgess (Lorcacerin). This medication has been in clinical trials over the past several years and works…
Another exciting topic at this year’s Obesity Medicine Association conference examined the link between sleep and obesity. In fact, this is one of the few lectures that kept me awake 🙂 Did you know that we actually burn calories while…
After a full week of lectures at the American Society of Bariatric Physician’s conference last week, I must say – I’ve never heard so many lectures about fat. There was much conjecture over whether or not fat is good or…
